As of June 2023 Astellas Pharma has a market cap of $30.21 Billion. This makes Astellas Pharma the world's 591th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $30.21 B | 10.23% |
2022 | $27.41 B | -9% |
2021 | $30.12 B | 4.91% |
2020 | $28.71 B | -10.48% |
2019 | $32.07 B | 31.36% |
2018 | $24.41 B | -4.91% |
2017 | $25.67 B | -10.6% |
2016 | $28.72 B | -7.29% |
2015 | $30.98 B | -0.53% |
2014 | $31.14 B | 19.18% |
2013 | $26.13 B | 25.5% |
2012 | $20.82 B | 11.87% |
2011 | $18.61 B | 7.98% |
2010 | $17.23 B | -8.15% |
2009 | $18.76 B | -9.69% |
2008 | $20.78 B | -15.52% |
2007 | $24.59 B | -5.74% |
2006 | $26.09 B | 84.92% |
2005 | $14.11 B |
On Jun 8th, 2023 the market cap of Astellas Pharma was reported to be: